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Julie Stenken, Twenty-First Century Chair in Proteomics 
Proteomics is the large-scale 
study of the structure and 
function of proteins. Julie 
Stenken, professor of 
chemistry and biochemistry, 
is leading a research team 
that received a four-year, 
$1.3 million grant from the 
National Institutes of Health 
to study the “foreign body” 
response to implants.
The challenges scientists have 
faced in developing reliable 
implantable glucose 
sensors are two-fold: the sensors must deal with the foreign-body reaction, where a person's 
body attempts to wall off the implanted material from healthy tissue, and just as importantly, 
blood chemistry and tissue vary from person to person. After a week, these natural 
phenomena cause erratic glucose readings from sensor implants, Stenken said.
“The whole foreign-body reaction drives a series of immune responses that then serve to 
encapsulate the sensor away from healthy tissue,” Stenken said. “This sensor is measuring 
glucose in an encapsulated ‘bag’ around the sensor rather than being able to sense what is out 
in healthy tissue. That becomes an extremely dangerous situation clinically, because if you 
dose with insulin when you don't need to, the person can go into diabetic coma or eventually 
death due to an inaccurate reading from the sensor.”
Stenken is a leading expert in the area of in vivo (in the body) collection of proteins known as 
cytokines using a technique called microdialysis sampling. Her aim is to understand the 
inflammatory response caused by cells called macrophages to implanted foreign materials.
Stenken is collaborating on the grant with Jeannine Durdik, professor of biological sciences and 
assistant dean for research in the Fulbright College of Arts and Sciences, and Liping Tang, 
professor of bioengineering at the University of Texas at Arlington.
Learn More 
University Honors NSF CAREER 
Award Winners
  
The University of Arkansas held a reception at Wallace W. 
and Jama M. Fowler House on June 5 for faculty who have 
been awarded funding by the National Science Foundation 
through the Faculty Early Career Development Program, 
better known as a CAREER award.
The office of vice provost for research and economic 
development sponsored the event, which honored 
university faculty who received CAREER awards. The 
university has received 27 CAREER awards since the 
program's inception in 1992, and is currently home to 19 
awardees.
The CAREER award is one of the highest honors given by 
the foundation to junior faculty members. Recipients are 
selected based on high-quality research and the 
integration of that research with education initiatives in 
the context of the university's mission. The award 
provides a minimum of $400,000 support for five years, or 
five years and $500,000 for those in biological sciences or 
polar programs.
Faculty who have received CAREER awards who are 
currently at the U of A, listed in alphabetical order: 
Laurent Bellaiche, physics; Luca Capogna, mathematical 
sciences; Greg Dumond, geosciences; Julian Fairey, civil 
engineering; Ingrid Fritsch, chemistry and biochemistry; 
Colin Heyes, chemistry and biochemistry; Russ Meller, 
industrial engineering; Lin Oliver, physics; Xianghong 
Qian, chemical engineering; Doug Spearot, mechanical 
engineering; Julie Stenken, chemistry and biochemistry; 
Susanne Striegler, chemistry and biochemistry; Jak 
Tchakhalian, physics; Paul Thibado, physics; Feng Wang, 
chemistry and biochemistry; Ranil Wickramasinghe, 
chemical engineering; Shui-Qing “Fisher” Yu, electrical 
engineering; David Zaharoff, biomedical engineering; Nan 
Zheng, chemistry and biochemistry; and Min Zou, 
mechanical engineering. 
 
Genders Communicate Consent 
to Sex Differently
A University of Arkansas researcher’s work on the way 
men and women communicate their consent to have sex 
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The following is a sampling 
of faculty awards in June, 
with the principal 
investigator, the award 
amount and the sponsor. An 
asterisk (*) indicates the 
continuation of a previous 
award. 
 
• Frank Millett, $1,042,877, 
National Institutes of 
Health* 
• Fisher Yu, $300,002, 









assistant professor of 
community health 
promotion in the 
College of Education 
and Health 
Professions, surveyed 
185 students at 
Indiana University, 
where she earned a doctorate in health behavior. She 
wanted to examine how college students define consent 
and how they express and interpret consent in real-life 
sexual interactions.
Her study found that the use of nonverbal cues to 
interpret consent to sexual intercourse could lead to 
miscommunication and, in some cases, could result in 
unwanted sexual advances and sexual assault. She found 
significant differences in how men and women 
communicated their consent to intercourse with women 
using more verbal strategies and men using more non-
verbal strategies. She found men also relied more on non-
verbal indicators when interpreting their partner’s consent 





Researchers at the 
University of Arkansas 
have identified that 
water, when chilled to 
a very low 
temperature, 
transforms into a new 
form of liquid.
Through a simulation 
performed in 
“supercooled” water, a 




liquid” phase transition 
• Fran Hagstrom, $223,078, 
Arkansas Department of 
Workforce Education 
• Daniel Lessner, $210,630, 
National Science Foundation 
• Fred Limp, $135,000, 
Arkansas Natural and 
Cultural Resources Council
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at 207 Kelvins, or 87 degrees below zero on the 
Fahrenheit scale.
The properties of supercooled water are important for 
understanding basic processes during cryoprotection, 
which is the preservation of tissue or cells by liquid 
nitrogen so they can be thawed without damage, said 
Wang, an associate professor in the department of 
chemistry and biochemistry in the J. William Fulbright 
College of Arts and Sciences.
The findings were published online July 8 in the 
journal Proceedings of the National Academy of Sciences. 
Wang wrote the article, “Liquid–liquid transition in 
supercooled water suggested by microsecond 
simulations.” Research associates Yaping Li and Jicun Li 
assisted with the study.
 
Learn More  
 
CONTACT US
Vice Provost for Research and Economic Development 
205 Administration Building 
1 University of Arkansas 






Probing for Answers Improving Sensors for Diabetics by 
Re-directing Macrophages 
By Chris Branam 
It's easy to measure glucose in a beaker.
But the simple sugar is hard to quantify directly in the human body, which is why long-term 
glucose monitoring for people with type 1 and type 2 diabetes through implantable devices 
has proven to be extremely difficult. Leland Clark of Cincinnati Children's Hospital, 
considered the "Father of Biosensors," first suggested the use of electrodes for measurement 
of glucose in humans with diabetes in 1962. But a half-century later, diabetics still do not 
have ways to better manage their diabetes other than finger sticks or implanted sensors that 
have to be replaced every five to seven days.
The challenges scientists have faced in developing reliable implantable glucose sensors are 
two-fold: the sensors must deal with the foreign-body reaction, where a person's body 
attempts to wall off the implanted material from healthy tissue, and just as importantly, 
blood chemistry and tissue vary from person to person. After a week, these natural 
phenomena cause erratic glucose readings from sensor implants, said Julie Stenken, 
professor of chemistry and biochemistry.
"The whole foreign-body reaction drives a series of immune responses that then serve to 
encapsulate the sensor away from healthy tissue," Stenken said. "This sensor is measuring 
glucose in an encapsulated 'bag' around the sensor rather than being able to sense what is 
out in healthy tissue. That becomes an extremely dangerous situation clinically, because if 
you dose with insulin when you don't need to, the person can go into diabetic coma or 
eventually death due to an inaccurate reading from the sensor."
Stenken is a leading expert in the area of in vivo (in the body) collection of proteins known 
as cytokines using a technique called microdialysis sampling. Her aim is to understand the 
inflammatory response caused by cells called macrophages to implanted foreign materials. 
But first she must ask the question: How can we change the way these cells communicate 
with each other?
Research to Extend Lives
 
Big numbers illustrate the importance of Julie Stenken's work. An estimated 26 million 
Americans have diabetes, and another 79 million are experiencing symptoms of pre-
diabetes, according to the American Diabetes Association. The association estimated the 
total annual cost of diabetes in the United States to be $218 billion in 2007, the last year 
figures were available. That total included direct medical costs and indirect costs such as 
disability, work loss and premature death.
Even with the numbers of diabetics growing by an estimated 2 million a year, according to 
the association, only two companies are currently marketing implantable glucose sensors to 
American diabetics. A third discontinued its model in 2011. Type 1diabetes is a serious 
medical condition. Extending the implanted glucose sensor's lifetime is crucial to the future 
well-being of this large population, Stenken said.
"Current glucose sensors still have to be calibrated against a finger stick on a regular basis," 
Stenken said. "So if you had a glucose sensor that was better integrated into the body, 
where you could reduce the calibrations that you need — and have it last a longer period of 
time — people would be more compliant with their insulin doses. It would be very helpful 
in managing their disease."
Also, episodes of nocturnal hypoglycemia are of particular concern for diabetics who rely 
on glucose sensors. When blood glucose drops to low levels during sleep, the person 
experiences symptoms such as headache, fatigue or night sweats. Untreated nocturnal 
hypoglycemia can cause the sufferer to slip into a diabetic coma. Scientists are working to 
create a glucose sensor that would signal an alert that would remind the person to consume 
carbohydrate.
The Host Response 
Understanding the underlying biochemistry that occurs at the site of an implanted 
biomaterial is important in a wide range of clinical contexts, from reconstructive surgery to 
implantable glucose sensors. Many of the problems that scientists have encountered in the 
development of implanted sensors into living things have been due to the lack of 
understanding of the host response to implanted materials, said Stenken, the Twenty-First 
Century Chair in Proteomics in the J. William Fulbright College of Arts and Sciences.
"In this whole process, the macrophage 
cells that are ultimately encapsulating this 
device communicate with each other 
through protein signals," Stenken said. 
"These messenger proteins, called 
cytokines, are part of a whole series of 
proteins that are involved in network 
responses within the immune system. We 
need to understand this communication 
process between all the cells so that we 
can direct the cells to the state where we 
want them to be."
This chemical signaling response to an 
artificial material within a tissue includes 
large cells known as macrophages. In an 
immune response, it is the job of the 
macrophage to destroy a foreign object, 
typically a virus or bacteria. The term is 
literally translated from Greek as "big 
eater." When the macrophages discover 
that they cannot destroy an object as large 
as a glucose sensor, they signal for 
fibroblast cells to lay down collagen, a 
group of proteins that form the main 
structural component of animal 
connective tissue. This "glue" eventually encapsulates an object, in this case a glucose 
sensor.
"There's an enormous interest in trying to redirect or bioengineer this whole process to 
improve outcomes," Stenken said. "These macrophages are very plastic. They have 
different states. We're trying to direct the macrophages to a certain type of cell, the M2. The 
M1 state is the classically activated macrophage where it is trying to destroy foreign 
material as quickly as possible. It's pro-inflammatory. The M2 state is considered to 
promote a wound-healing state."
To direct the macrophages, Stenken's research group uses a microdialysis probe that is 
placed under the skin of rats in order to mimic an implanted glucose sensor. The 
researchers, in a process unique to this group, then infuse different agents through the probe 
that are hypothesized to direct the macrophages into the M2, or healing, state.
"Once they are driven into the healing state, the question is, 'Do you see a longer lifetime 
for the implant?'" she said.
Stenken's work has drawn the attention of researchers across the country, including William 
M. Reichert, a distinguished professor of biomedical engineering at Duke University who 
has worked on biosensors.
"Julie has almost single handedly made a finicky microdialysis system work for the 
monitoring of wound healing," Reichert said. "I did some of this in the past but more or less 
gave up because of all of the experimental problems that she somehow overcomes. This can 
only be the mark of a careful and skilled experimentalist."
Federally Funded Research
In 2007, Stenken came to the U of A to accept an appointment as the inaugural holder of the 
Twenty-First Century Chair in Proteomics. The chair was endowed with a $1.5 million gift 
raised by the university's Campaign for the Twenty-First Century. She brought with her 
ongoing microdialysis research that included two grants totaling more than $1 million from 
the National Institutes of Health.
In addition to the current NIH grant, Stenken received a two-year, $375,000 grant from the 
national institutes to use the microdialysis probe to study cytokines in the brain. The 
Exploratory Developmental Research Grant (R21) will help to develop analytical chemistry 
methods to collect and detect cytokine proteins to allow for rapid translational medical 
treatments for humans. Cytokines as well as other neuropeptides are known to affect 
different human diseases related to the brain including, but not limited to, alcoholism, 
anxiety, appetite, depression, epilepsy, multiple sclerosis, pain, sleep, and various 
psychiatric disorders. These peptides and proteins are difficult to measure in the living 
brain.
"Cytokines are now considered the third-generation chemical communication system in the 
brain behind neurotransmitters and neuropeptides," Stenken said. "People have been very 
interested in cytokines in the brain because there are known receptors and they show up in 
many neurodegenerative diseases."
NIH R21 grants are meant to encourage high risk/high return research efforts. Stenken is 
enthusiastic about the possibilities.
"There are many biological areas that I know that these microdialysis probes will prove to 
be beneficial," she said. "I'm not afraid to learn new things in biology."
Stenken and Proteomics
Proteomics is the large-scale study of the structure and function of proteins. Julie Stenken is 
leading a research team that received a four-year, $1.3 million grant from the National 
Institutes of Health to study the "foreign body" response to implants. 
Stenken is collaborating on the grant with Jeannine Durdik, professor of biological sciences 
and assistant dean for research in the Fulbright College of Arts and Sciences, and Liping 
Tang, professor of bioengineering at the University of Texas at Arlington. 
In 2009, Stenken co-edited In Vivo Glucose Sensing with David D. Cunningham of Abbott 
Laboratories. The book, part of the Wiley Chemical Analysis series, is designed to provide 
state-of-the-art information on glucose monitoring to clinicians and medical educators.
Photos by Russell Cothren
Office of University Relations, University of Arkansas • Davis Hall, Fayetteville Arkansas, 
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Research: Genders Communicate Consent to Sex 
Differently
Professor suggests implications for sexual assault prevention efforts
Tuesday, July 02, 2013
FAYETTEVILLE, Ark. – A University 
of Arkansas researcher’s work on the 
way men and women communicate 
their consent to have sex could lead to 
improved sexual assault prevention 
programs on college campuses.
Kristen Jozkowski, assistant professor 
of community health promotion in 
the College of Education and Health 
Professions, surveyed 185 students at 
Indiana University, where she earned a doctorate in health behavior. She wanted to 
examine how college students define consent and how they express and interpret 
consent in real-life sexual interactions.
 Her study found that the use of nonverbal cues to interpret consent to sexual 
intercourse could lead to miscommunication and, in some cases, could result in 
unwanted sexual advances and sexual assault. She found significant differences in 
how men and women communicated their consent to intercourse with women 
using more verbal strategies and men using more non-verbal strategies. She found 
men also relied more on non-verbal indicators when interpreting their partner’s 
consent and non-consent than women did. 
“The ways men and women look for cues to indicate consent and interpret them 
differs and this could potentially lead to unwanted sex,” Jozkowski said. “We all 
talk in code.”
For example, when she conducted interviews with college students, Jozkowski said, 
a male participant described how college students communicate in code. He 
indicated that he may ask a woman to come to his house and watch a movie. 
Because of the context of their relationship and the timing of the invitation, he may 
interpret that invitation as an invitation for sex. In a different context with 
potentially a different woman, he may just mean watching a movie.
Analyses of how participants actually communicated and interpreted consent 
suggested that many college students, despite defining consent as an explicit 
communication of agreement, often use consent signals that are less clear than 
providing explicit permission or saying yes, Jozkowski found. Sexual assault 
prevention education that addresses gender differences in consent communication 
may help men and women see the value in direct, verbal communication of 
consent, she said.
“They are saying something, but meaning something else, and they think the 
intended message is well understood given other contextual cues,” Jozkowski said. 
“But what is really going on from our analyses is that men and women have 
disjunctive views of consent. Both think they understand each other but really the 
two (men and women) have different understandings of what these codes mean.”
Many sexual assault prevention efforts focus on clear communication of consent as 
a way to reduce sexual assault but little research examines how heterosexual college 
students conceptualize sexual consent, she said. Most colleges and universities 
provide sexual assault prevention education to students but incident rates have not 
fallen over the past 50 years.
Jozkowski is lead author of “Gender Differences in Heterosexual College Students’ 
Conceptualizations and Indicators of Sexual Consent: Implications for 
Contemporary Sexual Assault Prevention Education” scheduled to be published 
later this year in the Journal of Sex Research and “College Students and Sexual 
Consent: Unique Insights,” also scheduled to be published next month in the 
Journal of Sex Research 
(http://www.tandfonline.com/doi/full/10.1080/00224499.2012.700739#.UdGKtpze7e4) 
and currently available online.
Contacts:
Kristen Jozkowski, assistant professor of community health promotion  
College of Education and Health Professions  
479-575-4111, kjozkows@uark.edu (mailto:kjozkows@uark.edu) 
Heidi Stambuck, director of communications  
College of Education and Health Professions  
479-575-3138, stambuck@uark.edu (mailto:stambuck@uark.edu) 
Feng Wang, University of Arkansas
University of Arkansas
Arkansas Newswire 
University of Arkansas Researchers Identify 
Transformation in Low-Temperature Water
'Liquid-liquid' phase transition occurs at 87 degrees below zero
Wednesday, July 10, 2013
Researchers at the University of 
Arkansas have identified that water, 
when chilled to a very low 
temperature, transforms into a new 
form of liquid.
Through a simulation performed in 
“supercooled” water, a research team 
led by chemist Feng “Seymour” Wang, 
confirmed a “liquid-liquid” phase 
transition at 207 Kelvins, or 87 
degrees below zero on the Fahrenheit scale.
The properties of supercooled water are important for understanding basic 
processes during cryoprotection, which is the preservation of tissue or cells by 
liquid nitrogen so they can be thawed without damage, said Wang, an associate 
professor in the department of chemistry and biochemistry in the J. William 
Fulbright College of Arts and Sciences.
“On a microsecond time scale, the water did not actually form ice but it 
transformed into a new form of liquid,” Wang said. “The study provides strong 
supporting evidence of the liquid-liquid phase transition and predicted a 
temperature of minimum density if water can be cooled well below its normal 
freezing temperature. Our study shows water will expand at a very low temperature 
even without forming ice.” 
The findings were published online July 8 in the journal Proceedings of the 
National Academy of Sciences. Wang wrote the article, “Liquid–liquid transition in 
supercooled water suggested by microsecond simulations.” Research associates 
Yaping Li and Jicun Li assisted with the study.
The liquid–liquid phase transition in supercooled water has been used to explain 
many anomalous behaviors of water. Direct experimental verification of such a 
phase transition had not been accomplished, and theoretical studies from different 
simulations contradicted each other, Wang said.
The University of Arkansas research team investigated the liquid–liquid phase 
transition using a simulation model called Water potential from Adaptive Force 
Matching for Ice and Liquid (WAIL). While normal water is a high-density liquid, 
the low-density liquid emerged at lower temperatures, according to the simulation.
The research was supported by a National Science Foundation Faculty Early Career 
Development Award and by a startup grant from the U of A. The University of 
Arkansas High Performance Computing Center provided the main computational 
resource for the study.
Contacts:
Feng Wang, associate professor  
chemistry and biochemistry  
469-575-5625, fengwang@uark.edu (mailto:fengwang@uark.edu) 
Chris Branam, research communications writer/editor  
University Relations  
479-575-4737, cwbranam@uark.edu (mailto:cwbranam@uark.edu) 
